Legal Representation
Attorney
Julia M. Chester
USPTO Deadlines
Next Deadline
11 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
January 10, 2026
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 10, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 10, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 24, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 24, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 16, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 15, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 14, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Manufacturing services for others in the field of biologics; manufacturing services for others in the field of transient transfection technology; biomanufacturing for others, namely, manufacturing of gene therapy products using biological organisms in the manufacturing process; cell therapy manufacturing for others; providing technical information in the field of pharmaceutical manufacturing; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells
First Use Anywhere:
20231100
First Use in Commerce:
20231100
Class 042
Product research and development in the fields of biology and medical sciences; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biologics; pharmaceutical drug and biologics delivery technology development services, namely, research and development in the area of pharmaceutical drug and biologics delivery systems in the nature of viral vectors; biological research and analysis; consulting services in the fields of research and development of biologics; scientific and technological services, namely, scientific research, analysis and testing in the field of biological vectors; scientific research services in the field of cell modification; pharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others
First Use Anywhere:
20231100
First Use in Commerce:
20231100
Classification
International Classes
040
042